Immunogenic composition of hepatitis C and methods of use thereof
US6682909B2 · kind B2 · utility
3Cited by
4References
148Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2001 |
| Grant date | Jan 27, 2004 |
| Priority date | — |
| Expiry date | Sep 13, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24234
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides truncated HCV E2 polypepides. The invention HCV E2 polypeptides lack the HVR1 region that provides immune protection against HCV. The present invention also provides immunogenic compositions of such polypeptides and the methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.